Biolife Solutions (BLFS) Gains from Investment Securities (2018 - 2023)
Biolife Solutions (BLFS) posted quarterly Gains from Investment Securities of -$415000.0 for Q4 2023, up 70.48% year-over-year from -$243425.1 in Q4 2022, and up 73.73% quarter-over-quarter from -$1.6 million in Q3 2023.
Biolife Solutions (BLFS) Gains from Investment Securities (2018 - 2023) Analysis & Trends
Biolife Solutions (BLFS) has reported Gains from Investment Securities for 6 consecutive years, with -$415000.0 the latest figure, recorded in Q4 2023.
- In Q4 2023, Gains from Investment Securities rose 70.48% year-over-year to -$415000.0; the TTM figure through Sep 2024 stood at -$415000.0 (up 86.97% YoY), while the FY2023 annual figure was -$2.2 million, up 53.87% from the prior year.
- Gains from Investment Securities grew to -$415000.0 in Q4 2023 per BLFS's latest filing, from -$1.6 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $19.7 million in Q1 2019 and bottomed at -$3.6 million in Q2 2019.
- Historically, Gains from Investment Securities has averaged $366250.0 across 5 years, with a median of -$453000.0 in 2021.
- Annual changes were most pronounced in 2021 — Gains from Investment Securities plunged 6900.0% — and 2022, when it surged 1775.71%.
- Biolife Solutions' Gains from Investment Securities stood at $50000.0 in 2019, then slumped by 4246.0% to -$2.1 million in 2020, then surged by 186.3% to $1.8 million in 2021, then plunged by 178.59% to -$1.4 million in 2022, then surged by 70.48% to -$415000.0 in 2023.
- Business Quant data shows BLFS's Gains from Investment Securities at -$415000.0 in Q4 2023, -$1.6 million in Q3 2023, and -$918000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -415,000.00 |
| Dec 31, 2023 | -415,000.00 |
| Sep 30, 2023 | -1.58 Mn |
| Sep 30, 2023 | -1.58 Mn |
| Jun 30, 2023 | -918,000.00 |
| Jun 30, 2023 | -918,000.00 |
| Mar 31, 2023 | 720,000.00 |
| Mar 31, 2023 | 720,000.00 |
| Dec 31, 2022 | -1.41 Mn |
| Dec 31, 2022 | -1.41 Mn |
| Sep 30, 2022 | 2.35 Mn |
| Sep 30, 2022 | 2.35 Mn |
| Jun 30, 2022 | -2.36 Mn |
| Jun 30, 2022 | -2.36 Mn |
| Mar 31, 2022 | -3.34 Mn |
| Mar 31, 2022 | -3.34 Mn |
| Dec 31, 2021 | 1.79 Mn |
| Dec 31, 2021 | 1.79 Mn |
| Sep 30, 2021 | -140,000.00 |
| Sep 30, 2021 | -140,000.00 |